127 related articles for article (PubMed ID: 38134837)
1. A multiplex immunoprofiling approach for detecting the co-localization of breast cancer biomarkers using a combination of Alexafluor - Quantum dot conjugates and a panel of chromogenic dyes.
Sharaf SS; Lekshmi A; S A; K G A; Jyothi S P A; Chandrasekharan A; Somanathan T; Santhosh Kumar TR; K S
Pathol Res Pract; 2024 Jan; 253():155033. PubMed ID: 38134837
[TBL] [Abstract][Full Text] [Related]
2. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
3. Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens.
Surace M; DaCosta K; Huntley A; Zhao W; Bagnall C; Brown C; Wang C; Roman K; Cann J; Lewis A; Steele K; Rebelatto M; Parra ER; Hoyt CC; Rodriguez-Canales J
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735177
[TBL] [Abstract][Full Text] [Related]
4. Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots.
Fountaine TJ; Wincovitch SM; Geho DH; Garfield SH; Pittaluga S
Mod Pathol; 2006 Sep; 19(9):1181-91. PubMed ID: 16778828
[TBL] [Abstract][Full Text] [Related]
5. Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgical specimens from FFPE breast cancer tissues.
Berg D; Langer R; Tran K; Walch A; Schuster T; Bronger H; Becker KF
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):300-5. PubMed ID: 21293257
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Aimi F; Procopio MG; Alvarez Flores MT; Brouland JP; Piazzon N; Brajkovic S; Dupouy DG; Gijs M; de Leval L
Virchows Arch; 2019 Sep; 475(3):313-323. PubMed ID: 31267199
[TBL] [Abstract][Full Text] [Related]
7. A validation study of quantum dot multispectral imaging to evaluate hormone receptor status in ductal carcinoma in situ of the breast.
Yu J; Monaco SE; Onisko A; Bhargava R; Dabbs DJ; Cieply KM; Fine JL
Hum Pathol; 2013 Mar; 44(3):394-401. PubMed ID: 23039940
[TBL] [Abstract][Full Text] [Related]
8. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform.
Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF
Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700
[TBL] [Abstract][Full Text] [Related]
9. A clinically feasible diagnostic spectro-histology built on SERS-nanotags for multiplex detection and grading of breast cancer biomarkers.
Murali VP; Karunakaran V; Murali M; Lekshmi A; Kottarathil S; Deepika S; Saritha VN; Ramya AN; Raghu KG; Sujathan K; Maiti KK
Biosens Bioelectron; 2023 May; 227():115177. PubMed ID: 36871528
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies.
Snyder EL; Bailey D; Shipitsin M; Polyak K; Loda M
Lab Invest; 2009 Aug; 89(8):857-66. PubMed ID: 19488035
[TBL] [Abstract][Full Text] [Related]
11. Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.
Yang XQ; Chen C; Peng CW; Hou JX; Liu SP; Qi CB; Gong YP; Zhu XB; Pang DW; Li Y
Int J Nanomedicine; 2011; 6():2265-73. PubMed ID: 22072864
[TBL] [Abstract][Full Text] [Related]
12. Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
Annaratone L; Simonetti M; Wernersson E; Marchiò C; Garnerone S; Scalzo MS; Bienko M; Chiarle R; Sapino A; Crosetto N
Oncotarget; 2017 Mar; 8(12):18680-18698. PubMed ID: 28423635
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells.
Rakovich TY; Mahfoud OK; Mohamed BM; Prina-Mello A; Crosbie-Staunton K; Van Den Broeck T; De Kimpe L; Sukhanova A; Baty D; Rakovich A; Maier SA; Alves F; Nauwelaers F; Nabiev I; Chames P; Volkov Y
ACS Nano; 2014 Jun; 8(6):5682-95. PubMed ID: 24873349
[TBL] [Abstract][Full Text] [Related]
14. Deep learning-based image analysis methods for brightfield-acquired multiplex immunohistochemistry images.
Fassler DJ; Abousamra S; Gupta R; Chen C; Zhao M; Paredes D; Batool SA; Knudsen BS; Escobar-Hoyos L; Shroyer KR; Samaras D; Kurc T; Saltz J
Diagn Pathol; 2020 Jul; 15(1):100. PubMed ID: 32723384
[TBL] [Abstract][Full Text] [Related]
15. Digital validation of breast biomarkers (ER, PR, AR, and HER2) in cytology specimens using three different scanners.
Salama AM; Hanna MG; Giri D; Kezlarian B; Jean MH; Lin O; Vallejo C; Brogi E; Edelweiss M
Mod Pathol; 2022 Jan; 35(1):52-59. PubMed ID: 34518629
[TBL] [Abstract][Full Text] [Related]
16. Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer.
Sun JZ; Chen C; Jiang G; Tian WQ; Li Y; Sun SR
Int J Nanomedicine; 2014; 9():1339-46. PubMed ID: 24648732
[TBL] [Abstract][Full Text] [Related]
17. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
Wang HY; Park S; Kim S; Ahn S; Lee D; Kim S; Jung D; Park KH; Lee H
Int J Clin Exp Pathol; 2014; 7(9):5792-800. PubMed ID: 25337220
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.
Akturk G; Sweeney R; Remark R; Merad M; Gnjatic S
Methods Mol Biol; 2020; 2055():497-519. PubMed ID: 31502167
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared quantum dots for HER2 localization and imaging of cancer cells.
Rizvi SB; Rouhi S; Taniguchi S; Yang SY; Green M; Keshtgar M; Seifalian AM
Int J Nanomedicine; 2014; 9():1323-37. PubMed ID: 24648731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
